232 related articles for article (PubMed ID: 6603573)
41. Biochemistry and biology of anaphylatoxins.
Hugli TE
Complement; 1986; 3(3):111-27. PubMed ID: 3542363
[TBL] [Abstract][Full Text] [Related]
42. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
Langone JJ; Das C; Bennett D; Terman DS
J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
[TBL] [Abstract][Full Text] [Related]
43. Isolation and characterization of cholecystokinin-58 (CCK-58) from porcine brain.
Tatemoto K; Jörnvall H; Siimesmaa S; Halldén G; Mutt V
FEBS Lett; 1984 Sep; 174(2):289-93. PubMed ID: 6468664
[TBL] [Abstract][Full Text] [Related]
44. Demonstration of a specific C3a receptor on guinea pig platelets.
Fukuoka Y; Hugli TE
J Immunol; 1988 May; 140(10):3496-501. PubMed ID: 3283237
[TBL] [Abstract][Full Text] [Related]
45. Factor C3f is a spasmogenic fragment released from C3b by factors I and H: the heptadeca-peptide C3f was synthesized and characterized.
Ganu VS; Müller-Eberhard HJ; Hugli TE
Mol Immunol; 1989 Oct; 26(10):939-48. PubMed ID: 2531841
[TBL] [Abstract][Full Text] [Related]
46. The primary structure of chicken muscle acylphosphatase isozyme Ch2.
Ohba Y; Minowa O; Mizuno Y; Shiokawa H
J Biochem; 1987 Nov; 102(5):1221-9. PubMed ID: 2830254
[TBL] [Abstract][Full Text] [Related]
47. Cardiac dysfunction caused by purified human C3a anaphylatoxin.
del Balzo UH; Levi R; Polley MJ
Proc Natl Acad Sci U S A; 1985 Feb; 82(3):886-90. PubMed ID: 2579381
[TBL] [Abstract][Full Text] [Related]
48. Immunopharmacology of anaphylatoxin-induced bronchoconstrictor responses.
Stimler-Gerard NP
Complement; 1986; 3(3):137-51. PubMed ID: 3026723
[TBL] [Abstract][Full Text] [Related]
49. Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).
Sorgenfrei J; Damerau B; Vogt W
Agents Actions; 1982 Apr; 12(1-2):118-21. PubMed ID: 6177210
[TBL] [Abstract][Full Text] [Related]
50. Plasma anaphylatoxin concentrations in inflammatory skin diseases.
Terui T; Takematsu H; Kato T; Ohkohchi K; Tagami H
Tohoku J Exp Med; 1987 Feb; 151(2):245-52. PubMed ID: 3495048
[TBL] [Abstract][Full Text] [Related]
51. Induction of thromboxane release from macrophages by anaphylatoxic peptide C3a of complement and synthetic hexapeptide C3a 72-77.
Hartung HP; Bitter-Suermann D; Hadding U
J Immunol; 1983 Mar; 130(3):1345-9. PubMed ID: 6600482
[TBL] [Abstract][Full Text] [Related]
52. C3a-induced contraction of guinea pig ileum consists of two components: fast histamine-mediated and slow prostanoid-mediated.
del Balzo U; Polley MJ; Levi R
J Pharmacol Exp Ther; 1989 Mar; 248(3):1003-9. PubMed ID: 2467976
[TBL] [Abstract][Full Text] [Related]
53. Role of the complement anaphylatoxins in inflammation and hypersensitivity reactions in the lung.
Stimler-Gerard NP
Surv Synth Pathol Res; 1985; 4(5-6):423-42. PubMed ID: 3879815
[No Abstract] [Full Text] [Related]
54. Induction of platelet aggregation by the complement-derived peptides C3a and C5a.
Grossklaus C; Damerau B; Lemgo E; Vogt W
Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):71-6. PubMed ID: 1004644
[TBL] [Abstract][Full Text] [Related]
55. Amino acid sequence of guinea pig C3a anaphylatoxin.
Gerard NP; Lively MO; Gerard C
Protein Seq Data Anal; 1988; 1(6):473-8. PubMed ID: 3064079
[TBL] [Abstract][Full Text] [Related]
56. Increased anaphylatoxins (C3a and C4a) in psoriatic sera.
Ohkohchi K; Takematsu H; Tagami H
Br J Dermatol; 1985 Aug; 113(2):189-96. PubMed ID: 3875363
[TBL] [Abstract][Full Text] [Related]
57. Cellular responses of guinea-pig macrophages to C4a; inhibition of C3a-induced O2- generation by C4a.
Murakami Y; Yamamoto T; Imamichi T; Nagasawa S
Immunol Lett; 1993 Jun; 36(3):301-4. PubMed ID: 8396560
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and properties of new bradykinin potentiating peptides.
Tominaga M; Stewart JM
J Med Chem; 1975 Feb; 18(2):130-3. PubMed ID: 1120978
[TBL] [Abstract][Full Text] [Related]
59. Human anaphylatoxin C4a is a potent agonist of the guinea pig but not the human C3a receptor.
Lienenklaus S; Ames RS; Tornetta MA; Sarau HM; Foley JJ; Crass T; Sohns B; Raffetseder U; Grove M; Hölzer A; Klos A; Köhl J; Bautsch W
J Immunol; 1998 Sep; 161(5):2089-93. PubMed ID: 9725198
[TBL] [Abstract][Full Text] [Related]
60. Release of leukotrienes from guinea pig lung stimulated by C5ades Arg anaphylatoxin.
Stimler NP; Bach MK; Bloor CM; Hugli TE
J Immunol; 1982 May; 128(5):2247-52. PubMed ID: 6174625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
